Shenzhen Mindray Bio-Medical Electronics (300760.CH) - Shareholders' Stock Selling and the Outlook
Original shareholders' share reduction leads to concerns on Mindray's outlook. Mindray is hard to go back to its high valuation and high growth in...
342 Views
Northbound Flows Monthly (Feb): CATL, Hundsun, Ping An Insurance, Inovance, Xinghuacun Fen Wine
We analyzed the Shanghai/Shenzhen Connect Scheme for February and highlight flows for CATL, Hundsun, Ping An Insurance, Inovance, Xinghuacun Fen Wine.
306 Views
China's 2023 Government Work Report in 14th NPC - The Highlights and the Outlook
We analyzed our interpretation on China's 2023 Government Work Report in 14th NPC, including GDP growth, CPI, fiscal/monetary policy, valuation...
382 Views
Lu DaoPei Medical Group Pre-IPO - Ramp up in Progress but Looks Promising
Lu Daopei Medical Group (1816743D CH) is looking to raise around US$400m in its upcoming Hong Kong IPO. LDPM has supported its growth through its...
336 Views
2023 High Conviction Update: Sonoscape Medical (300633.CH) - High Growth Is Expected to Continue
We're optimistic about Sonoscape's 2022 results.High growth continues in 2023.Based on our forecast, there's still growth space in valuation.Under...
486 Views